IM Cannabis Corp. announced that its common shares commenced trading on the Nasdaq Capital Market on a 30:1 consolidated basis effective August 27, 2026. This reverse stock split reduced the outstanding share count from approximately 18.57 million to roughly 619,000 shares. The company stated this action was taken to regain compliance with Nasdaq’s minimum bid price requirement of $1.00 per share. Fractional shares were handled via rounding or cancellation, and convertible securities were proportionately adjusted. IM Cannabis Corp. operates in the medical cannabis industry, importing and distributing cannabis products to patients in Israel and Germany.
